Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
0.9613
-0.0387 (-3.87%)
Jun 4, 2025, 1:54 PM - Market open

Advanced Biomed Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21
Selling, General & Admin
1.631.661.690.750.1
Research & Development
0.880.881.381.621.73
Operating Expenses
2.512.543.072.371.84
Operating Income
-2.51-2.54-3.07-2.37-1.84
Interest & Investment Income
0.050.050.0200
Currency Exchange Gain (Loss)
-0.29-0.29-0.51--
Other Non Operating Income (Expenses)
-0.610-0.02-0.04-0
EBT Excluding Unusual Items
-3.37-2.78-3.58-2.41-1.84
Impairment of Goodwill
----1.62-
Gain (Loss) on Sale of Assets
---0.15--
Pretax Income
-3.37-2.78-3.73-4.03-1.84
Net Income
-3.37-2.78-3.73-4.03-1.84
Net Income to Common
-3.37-2.78-3.73-4.03-1.84
Shares Outstanding (Basic)
2020201411
Shares Outstanding (Diluted)
2020201411
Shares Change (YoY)
0.70%0.32%40.55%23.74%-
EPS (Basic)
-0.17-0.14-0.19-0.28-0.16
EPS (Diluted)
-0.17-0.14-0.19-0.28-0.16
Free Cash Flow
-4.82-2.2-3.17-1.63-0.5
Free Cash Flow Per Share
-0.24-0.11-0.16-0.12-0.04
EBITDA
-2.21-2.27-2.84-2.26-1.78
D&A For EBITDA
0.30.270.230.110.06
EBIT
-2.51-2.54-3.07-2.37-1.84
Updated Jan 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q